PE20010642A1 - Combinacion de pramipexol y clonidina para el tratamiento del sindrome de piernas inquietas - Google Patents
Combinacion de pramipexol y clonidina para el tratamiento del sindrome de piernas inquietasInfo
- Publication number
- PE20010642A1 PE20010642A1 PE2000000836A PE0008362000A PE20010642A1 PE 20010642 A1 PE20010642 A1 PE 20010642A1 PE 2000000836 A PE2000000836 A PE 2000000836A PE 0008362000 A PE0008362000 A PE 0008362000A PE 20010642 A1 PE20010642 A1 PE 20010642A1
- Authority
- PE
- Peru
- Prior art keywords
- combination
- pramipexol
- clonidine
- treatment
- restless legs
- Prior art date
Links
- FASDKYOPVNHBLU-ZETCQYMHSA-N pramipexole Chemical compound C1[C@@H](NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-ZETCQYMHSA-N 0.000 title abstract 4
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 title abstract 3
- 208000005793 Restless legs syndrome Diseases 0.000 title abstract 3
- 229960002896 clonidine Drugs 0.000 title abstract 3
- 239000000556 agonist Substances 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 abstract 1
- 239000003604 miotic agent Substances 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMBINACION QUE COMPRENDE a)DE 0,01 mg A 1 mg DE CLONIDINA O 2-(2,6-DICLORO-ANILINO)-4,5-DIHIDRO-IMIDAZOL; b)DE 0,05 A 2 mg DE PRAMIPEXOL O (S)-2-AMINO-6-n-PROPILAMINO-4,5,6,7-TETRAHIDRO-BENZOTIAZOL. LA COMBINACION SE FORMULA EN TABLETAS, CAPSULAS, EMPLASTO TRANSDERMICO, UTILIZANDOSE LAS SUSTANCIAS MEZCLADAS O SEPARADAS. EL PRAMIPEXOL ES UN AGENTE AGONISTA D2/D3 (ANTAGONISTA DE DOPAMINA) Y LA CLONIDINA ES UN AGENTE ANTIHIPERTONICO Y MIOTICO POR LO QUE LA COMBINACION PUEDE SER UTIL PARA EL TRATAMIENTO DEL SINDROME DE PIERNAS INQUIETAS (RLS)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19938825A DE19938825A1 (de) | 1999-08-19 | 1999-08-19 | Wirkstoffkombination mit Clonidin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010642A1 true PE20010642A1 (es) | 2001-06-08 |
Family
ID=7918574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000836A PE20010642A1 (es) | 1999-08-19 | 2000-08-17 | Combinacion de pramipexol y clonidina para el tratamiento del sindrome de piernas inquietas |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20020010201A1 (es) |
| EP (1) | EP1210081A2 (es) |
| JP (1) | JP2003507420A (es) |
| KR (1) | KR20020060163A (es) |
| AR (1) | AR025330A1 (es) |
| AU (1) | AU6440600A (es) |
| BR (1) | BR0013353A (es) |
| CA (1) | CA2376606A1 (es) |
| CO (1) | CO5200840A1 (es) |
| CZ (1) | CZ2002515A3 (es) |
| DE (1) | DE19938825A1 (es) |
| IL (1) | IL147741A0 (es) |
| MX (1) | MXPA02001138A (es) |
| NO (1) | NO20020793L (es) |
| PE (1) | PE20010642A1 (es) |
| PL (1) | PL353358A1 (es) |
| TR (1) | TR200200449T2 (es) |
| UY (1) | UY26293A1 (es) |
| WO (1) | WO2001013902A2 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| HUP0500001A3 (en) | 2001-12-11 | 2005-11-28 | Univ Virginia | Use of pramipexole to treat amyotrophic lateral sclerosis |
| DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
| US20040048779A1 (en) * | 2002-05-06 | 2004-03-11 | Erwin Schollmayer | Use of rotigotine for treating the restless leg syndrome |
| WO2004019949A1 (en) | 2002-08-30 | 2004-03-11 | Kyowa Hakko Kogyo Co. Ltd. | Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| DK1426049T3 (da) * | 2002-12-02 | 2005-08-22 | Sanol Arznei Schwarz Gmbh | Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom |
| US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
| DK2026803T3 (da) | 2006-05-16 | 2012-04-16 | Knopp Neurosciences Inc | Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf |
| WO2008009664A2 (en) * | 2006-07-19 | 2008-01-24 | Boehringer Ingelheim International Gmbh | Treatment of pain |
| US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
| AU2008224844B2 (en) | 2007-03-14 | 2012-08-09 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
| EP1987815A1 (en) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| CA2734491A1 (en) | 2008-08-19 | 2010-02-25 | Knopp Neurosciences, Inc. | Compositions and methods of using (r)-pramipexole |
| WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| WO2014105783A1 (en) * | 2012-12-28 | 2014-07-03 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
| ES3043076T3 (en) | 2013-07-12 | 2025-11-24 | Areteia Therapeutics Inc | Treating elevated levels of eosinophils and/or basophils |
| AU2014306683B2 (en) | 2013-08-13 | 2017-10-12 | Knopp Biosciences Llc | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders |
| EP3033081B1 (en) | 2013-08-13 | 2021-05-12 | Knopp Biosciences LLC | Compositions and methods for treating chronic urticaria |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
| DE4325491A1 (de) * | 1993-07-29 | 1995-02-02 | Boehringer Ingelheim Kg | Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels |
| US6001861A (en) * | 1998-01-16 | 1999-12-14 | Pharmacia & Upjohn Company | Use of pramipexole in the treatment of restless legs syndrome |
| DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
| WO2000054773A1 (en) * | 1999-03-12 | 2000-09-21 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
-
1999
- 1999-08-19 DE DE19938825A patent/DE19938825A1/de not_active Withdrawn
-
2000
- 2000-08-09 CA CA002376606A patent/CA2376606A1/en not_active Abandoned
- 2000-08-09 MX MXPA02001138A patent/MXPA02001138A/es unknown
- 2000-08-09 BR BR0013353-1A patent/BR0013353A/pt not_active Application Discontinuation
- 2000-08-09 PL PL00353358A patent/PL353358A1/xx not_active Application Discontinuation
- 2000-08-09 EP EP00951485A patent/EP1210081A2/de not_active Withdrawn
- 2000-08-09 WO PCT/EP2000/007718 patent/WO2001013902A2/de not_active Ceased
- 2000-08-09 TR TR2002/00449T patent/TR200200449T2/xx unknown
- 2000-08-09 JP JP2001518040A patent/JP2003507420A/ja active Pending
- 2000-08-09 KR KR1020027002149A patent/KR20020060163A/ko not_active Withdrawn
- 2000-08-09 AU AU64406/00A patent/AU6440600A/en not_active Abandoned
- 2000-08-09 CZ CZ2002515A patent/CZ2002515A3/cs unknown
- 2000-08-09 IL IL14774100A patent/IL147741A0/xx unknown
- 2000-08-15 UY UY26293A patent/UY26293A1/es not_active Application Discontinuation
- 2000-08-17 PE PE2000000836A patent/PE20010642A1/es not_active Application Discontinuation
- 2000-08-18 AR ARP000104292A patent/AR025330A1/es unknown
- 2000-08-18 CO CO00062317A patent/CO5200840A1/es not_active Application Discontinuation
-
2001
- 2001-10-04 US US09/970,839 patent/US20020010201A1/en not_active Abandoned
-
2002
- 2002-02-18 NO NO20020793A patent/NO20020793L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR025330A1 (es) | 2002-11-20 |
| KR20020060163A (ko) | 2002-07-16 |
| EP1210081A2 (de) | 2002-06-05 |
| PL353358A1 (en) | 2003-11-17 |
| UY26293A1 (es) | 2001-04-30 |
| CA2376606A1 (en) | 2001-03-01 |
| CZ2002515A3 (cs) | 2002-05-15 |
| BR0013353A (pt) | 2002-04-23 |
| WO2001013902A3 (de) | 2001-08-23 |
| JP2003507420A (ja) | 2003-02-25 |
| IL147741A0 (en) | 2002-08-14 |
| AU6440600A (en) | 2001-03-19 |
| WO2001013902A2 (de) | 2001-03-01 |
| DE19938825A1 (de) | 2001-04-26 |
| NO20020793D0 (no) | 2002-02-18 |
| NO20020793L (no) | 2002-02-18 |
| CO5200840A1 (es) | 2002-09-27 |
| US20020010201A1 (en) | 2002-01-24 |
| TR200200449T2 (tr) | 2002-08-21 |
| MXPA02001138A (es) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010642A1 (es) | Combinacion de pramipexol y clonidina para el tratamiento del sindrome de piernas inquietas | |
| PA8502901A1 (es) | Tratamiento de combinacion con il-1ra y compuestos que inhiben el procesamiento y la liberacion de il-1 | |
| CO5261563A1 (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
| NO20075427L (no) | Ny farmasoytisk formulering inneholdende et biguanid og et tiazolidindionderivat | |
| DE60238756D1 (de) | Opioid enthaltende arzneiform gegen missbrauch | |
| UY26296A1 (es) | Tratamiento medicamentoso del síndrome de piernas inquietas | |
| PE20020770A1 (es) | Formulaciones de entecavir de dosis bajas y uso | |
| CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| ES2192264T3 (es) | Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2(1h)-indol-2-ona (=ziprasidona), su preparacion y su uso como antagonista de la dopamina. | |
| UY26391A1 (es) | Inhibidores sglt2 de glucosidos de c-arilo y metodo | |
| ECSP077241A (es) | Formulación en comprimidos de liberación extendida que contiene pramipexol o una sal farmacéuticamente aceptable del mismo, método para su fabricación y su uso | |
| PE20061016A1 (es) | Una formulacion solida de dosificacion farmaceutica | |
| PE20081374A1 (es) | Combinacion que comprende un agente antipsicotico y (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina | |
| EE9900288A (et) | Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks | |
| PE83199A1 (es) | Composicion farmaceutica de tiazolidinadiona y biguanida para el tratamiento de la diabetes | |
| DE60134874D1 (de) | Benzodiazepin-derivate als gamma-secretase inhibitoren | |
| CL2004000643A1 (es) | Composicion farmaceutica que comprende un agonista de 5-ht 1b/1d y un inhibidor selectivo de ciclooxigenasa-2, util en el tratamiento de la migrana. | |
| CO5011043A1 (es) | Composicion farmaceutica que contiene un compuesto inhibidor ace y estabilizador, tabletas que la contienen y proceso para estabilizar inhibidores de ace | |
| CO5690568A2 (es) | Agonismo del receptor de 5ht2a para el tratamiento de disfun cion termorreguladora | |
| AR036658A1 (es) | Formulacion de dosificacion oral de fundicion instantanea | |
| PE20060594A1 (es) | Composicion farmaceutica que contiene un agonista de ppar | |
| TR200200978T2 (tr) | Yeni mirtazapin formülasyonu | |
| PE20030331A1 (es) | Melatonina y compuestos relacionados y medicamentos que los contienen para el tratamiento del insomnio primario | |
| UY27031A1 (es) | Uso de agonistas selectivos del receptor de dopamina d4 para tratar disfunción sexual | |
| BR0215064A (pt) | Agonistas receptores seletivos de dopamina d3 para o tratamento de disfunção sexual |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |